These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31672976)

  • 1. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.
    Rajaram S; Roth MA; Malato J; VandenBerg S; Hann B; Atreya CE; Altschuler SJ; Wu LF
    Sci Data; 2019 Oct; 6(1):253. PubMed ID: 31672976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
    Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
    Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line.
    Hassani I; Anbiah B; Kuhlers P; Habbit NL; Ahmed B; Heslin MJ; Mobley JA; Greene MW; Lipke EA
    Biofabrication; 2022 Jul; 14(4):. PubMed ID: 35617932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
    J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clonal evolution of metastatic colorectal cancer.
    Dang HX; Krasnick BA; White BS; Grossman JG; Strand MS; Zhang J; Cabanski CR; Miller CA; Fulton RS; Goedegebuure SP; Fronick CC; Griffith M; Larson DE; Goetz BD; Walker JR; Hawkins WG; Strasberg SM; Linehan DC; Lim KH; Lockhart AC; Mardis ER; Wilson RK; Ley TJ; Maher CA; Fields RC
    Sci Adv; 2020 Jun; 6(24):eaay9691. PubMed ID: 32577507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
    Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
    J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.
    Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
    Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
    Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
    J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
    Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
    Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.
    Offin M; Sauter JL; Tischfield SE; Egger JV; Chavan S; Shah NS; Manoj P; Ventura K; Allaj V; de Stanchina E; Travis W; Ladanyi M; Rimner A; Rusch VW; Adusumilli PS; Poirier JT; Zauderer MG; Rudin CM; Sen T
    Genome Med; 2022 Nov; 14(1):127. PubMed ID: 36380343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
    He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
    Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
    Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.
    White BS; Woo XY; Koc S; Sheridan T; Neuhauser SB; Wang S; Evrard YA; Chen L; Foroughi Pour A; Landua JD; Mashl RJ; Davies SR; Fang B; Raso MG; Evans KW; Bailey MH; Chen Y; Xiao M; Rubinstein JC; Sanderson BJ; Lloyd MW; Domanskyi S; Dobrolecki LE; Fujita M; Fujimoto J; Xiao G; Fields RC; Mudd JL; Xu X; Hollingshead MG; Jiwani S; Acevedo S; ; Davis-Dusenbery BN; Robinson PN; Moscow JA; Doroshow JH; Mitsiades N; Kaochar S; Pan CX; Carvajal-Carmona LG; Welm AL; Welm BE; Govindan R; Li S; Davies MA; Roth JA; Meric-Bernstam F; Xie Y; Herlyn M; Ding L; Lewis MT; Bult CJ; Dean DA; Chuang JH
    Cancer Res; 2024 Jul; 84(13):2060-2072. PubMed ID: 39082680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
    Sun H; Cao S; Mashl RJ; Mo CK; Zaccaria S; Wendl MC; Davies SR; Bailey MH; Primeau TM; Hoog J; Mudd JL; Dean DA; Patidar R; Chen L; Wyczalkowski MA; Jayasinghe RG; Rodrigues FM; Terekhanova NV; Li Y; Lim KH; Wang-Gillam A; Van Tine BA; Ma CX; Aft R; Fuh KC; Schwarz JK; Zevallos JP; Puram SV; Dipersio JF; ; Davis-Dusenbery B; Ellis MJ; Lewis MT; Davies MA; Herlyn M; Fang B; Roth JA; Welm AL; Welm BE; Meric-Bernstam F; Chen F; Fields RC; Li S; Govindan R; Doroshow JH; Moscow JA; Evrard YA; Chuang JH; Raphael BJ; Ding L
    Nat Commun; 2021 Aug; 12(1):5086. PubMed ID: 34429404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.
    Sato K; Niida A; Masuda T; Shimizu D; Tobo T; Kuroda Y; Eguchi H; Nakagawa T; Suzuki Y; Mimori K
    Cancer Genomics Proteomics; 2019; 16(1):21-27. PubMed ID: 30587497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.